Blackhall F - Search Results

1

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team. Faivre-Finn C, et al. Among authors: blackhall f. Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20. Lancet Oncol. 2017. PMID: 28642008 Free PMC article. Clinical Trial.

2

Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.

Blackhall FH, Shepherd FA. Blackhall FH, et al. Hematol Oncol Clin North Am. 2004 Oct;18(5):1121-41, ix. doi: 10.1016/j.hoc.2004.06.005. Hematol Oncol Clin North Am. 2004. PMID: 15474338 Review.

3

Chemotherapy for advanced non-small cell lung cancer patients with performance status 2.

Blackhall FH, Bhosle J, Thatcher N. Blackhall FH, et al. Curr Opin Oncol. 2005 Mar;17(2):135-9. doi: 10.1097/01.cco.0000152629.20996.9e. Curr Opin Oncol. 2005. PMID: 15725918 Review.

4

Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.

Thatcher N, Faivre-Finn C, Blackhall F, Anderson H, Lorigan P. Thatcher N, et al. Among authors: blackhall f. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5051s-5056s. doi: 10.1158/1078-0432.CCR-05-9004. Clin Cancer Res. 2005. PMID: 16000613 Free article. Review.

5

Where next for gefitinib in patients with lung cancer?

Blackhall F, Ranson M, Thatcher N. Blackhall F, et al. Lancet Oncol. 2006 Jun;7(6):499-507. doi: 10.1016/S1470-2045(06)70725-2. Lancet Oncol. 2006. PMID: 16750500 Review.

6

Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.

Baka S, Manegold C, Buchholz E, Schott-von-Römer K, Lorigan P, Nagel S, Blackhall F, Aschroft L, Thatcher N. Baka S, et al. Among authors: blackhall f. Lung Cancer. 2006 Aug;53(2):165-70. doi: 10.1016/j.lungcan.2006.04.010. Epub 2006 Jun 19. Lung Cancer. 2006. PMID: 16787686

7

Small cell lung cancer and targeted therapies.

Blackhall FH, Shepherd FA. Blackhall FH, et al. Curr Opin Oncol. 2007 Mar;19(2):103-8. doi: 10.1097/CCO.0b013e328011bec3. Curr Opin Oncol. 2007. PMID: 17272981 Review.

8

Three-gene prognostic classifier for early-stage non small-cell lung cancer.

Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, Strumpf D, Johnston MR, Darling G, Keshavjee S, Waddell TK, Liu N, Lau D, Penn LZ, Shepherd FA, Jurisica I, Der SD, Tsao MS. Lau SK, et al. J Clin Oncol. 2007 Dec 10;25(35):5562-9. doi: 10.1200/JCO.2007.12.0352. J Clin Oncol. 2007. PMID: 18065728

9

Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.

Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre-Finn C. Bayman NA, et al. Among authors: blackhall f. Clin Lung Cancer. 2008 Mar;9(2):92-101. doi: 10.3816/CLC.2008.n.014. Clin Lung Cancer. 2008. PMID: 18501095 Review.

10

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.

Baka S, Califano R, Ferraldeschi R, Aschroft L, Thatcher N, Taylor P, Faivre-Finn C, Blackhall F, Lorigan P. Baka S, et al. Among authors: blackhall f. Br J Cancer. 2008 Aug 5;99(3):442-7. doi: 10.1038/sj.bjc.6604480. Br J Cancer. 2008. PMID: 18665190 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page